ALS (ALQ) AI Stock Analysis

• Market Cap: $11.10B
• Dividend Yield: 1.76%
• Average Volume (3M): 1.43M
• Price to Earnings (P/E): 41.4
• Beta (1Y): 0.91
• Revenue Growth: 18.18%
• EPS Growth: 4272.22%
• Country: AU
• Employees: 19,565
• Sector: Industrials
• Sector Strength: 72
• Industry: Consulting Services
• EPS (TTM): 0.35
• Shares Outstanding: 507,199,650
• 10 Day Avg. Volume: 1,514,219
• 30 Day Avg. Volume: 1,429,263
• PEG Ratio: 0.02
• Price to Book (P/B): 5.83
• Price to Sales (P/S): 2.49
• P/FCF Ratio: 30.50
• Enterprise Value/Market Cap: 0.84
• Enterprise Value/Revenue: 3.12
• Enterprise Value/Gross Profit: 10.53
• Enterprise Value/Ebitda: 15.20
• 1Y Price Target: $22.63
• Price Target Upside: 2.84% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 11
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 66 Neutral
• Price Target: AU$22.00 ▼(-0.05% Downside)

ALS's strong financial performance is the most significant factor, supported by robust revenue growth and profitability. Technical analysis indicates a bullish trend, though caution is advised due to overbought signals. The valuation suggests the stock may be overvalued, which slightly offsets the positive financial and technical outlook.

Positive Factors

Revenue Growth

Consistent revenue growth indicates the company's expanding market reach and successful business model, supporting long-term stability.

Profitability

Improved profitability reflects efficient operations and cost management, enhancing the company's ability to reinvest and grow.

Cash Flow Generation

Strong cash flow generation supports operational needs and strategic investments, ensuring financial flexibility and resilience.

Negative Factors

Leverage Management

High leverage can limit financial flexibility and increase risk, potentially impacting the company's ability to invest and grow.

Operational Cost Pressures

Decreasing EBIT margins indicate rising operational costs, which could pressure profitability if not managed effectively.

Cash Conversion Efficiency

Inefficient cash conversion can hinder the company's ability to fund operations and growth, affecting long-term financial health.

ALS Business Overview & Revenue Model

Company Description

ALS Limited provides professional technical services primarily in the areas of testing, measurement, and inspection in Africa, Asia/Pacific, Europe, the Middle East, North Africa, and the Americas. The company operates through three segments: Life Sciences, Commodities, and Industrial. The Commodities segment offers assaying and analytical testing, and metallurgical services for the mining and mineral exploration companies in geochemistry, metallurgy, inspection, and coal quality streams. Its testing and consulting services cover the resource life cycle, including exploration, feasibility, optimization, production, design, development, trade, and rehabilitation. This segment also provides coal sampling, analysis and certification, formation evaluation, and related analytical testing services. The Life Sciences segment offers analytical testing and sampling, and remote monitoring services for the environmental, food, pharmaceutical, and consumer products markets; and microbiological, physical, and chemical testing services. This segment also provides analytical testing data to assist consulting and engineering firms, industries, and governments. The Industrial segment offers diagnostic testing and engineering solutions for the energy, resources, transportation, and infrastructure sectors. This segment serves asset owners, operators, constructors, and equipment manufacturers in the power, petrochemical, mining, minerals processing, water, infrastructure, and transportation industries. The company was formerly known as Campbell Brothers Limited and changed its name to ALS Limited in August 2012. ALS Limited was founded in 1863 and is headquartered in Milton, Australia.

How the Company Makes Money

ALS generates revenue through a diversified model that includes several key streams. Primarily, it earns money from laboratory testing services, where clients pay for the analysis of samples related to soil, water, air, and food safety. Additionally, the company provides inspection and certification services, which involve auditing and validating compliance with industry standards. ALS also offers technical consulting and advisory services, helping clients navigate regulatory frameworks and optimize their operations. Strategic partnerships with various industries enhance its service offerings and expand its client base, contributing to stable revenue growth. Seasonal fluctuations in demand for certain services can impact earnings, but the company's broad portfolio helps mitigate risks associated with specific market trends.

ALS Financial Statement Overview

Summary

ALS exhibits robust financial health with strong revenue growth and profitability. The balance sheet shows improved leverage, though it remains a point of attention. Cash flow generation is solid, supporting the company's operational and strategic initiatives.

Income Statement

ALS has demonstrated strong revenue growth with a 10.95% increase in the latest year, supported by a high gross profit margin of 89.80%. The net profit margin improved significantly to 8.54%, indicating enhanced profitability. However, the EBIT margin slightly decreased, suggesting some operational cost pressures.

Balance Sheet

The company's debt-to-equity ratio has improved, indicating better leverage management, but remains relatively high. Return on equity is strong at 21.30%, reflecting efficient use of equity. The equity ratio is stable, suggesting a balanced asset structure.

Cash Flow

ALS has shown positive free cash flow growth of 4.58%, and the operating cash flow to net income ratio is healthy, indicating good cash generation relative to earnings. However, the free cash flow to net income ratio suggests room for improvement in cash conversion efficiency.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	3.00B	3.00B	2.46B	2.28B	1.95B	1.76B
Gross Profit	888.50M	2.69B	2.19B	828.60M	693.90M	561.70M
EBITDA	615.80M	675.00M	641.40M	591.30M	439.10M	415.40M
Net Income	256.20M	256.20M	12.90M	291.20M	190.50M	169.60M
Balance Sheet
Total Assets	4.06B	4.06B	3.70B	3.33B	2.84B	2.48B
Cash, Cash Equivalents and Short-Term Investments	268.00M	268.00M	299.90M	179.60M	122.80M	168.60M
Total Debt	2.09B	2.09B	1.87B	1.45B	1.24B	967.70M
Total Liabilities	2.77B	2.77B	2.50B	1.95B	1.71B	1.40B
Stockholders Equity	1.28B	1.28B	1.18B	1.37B	1.12B	1.07B
Cash Flow
Free Cash Flow	244.60M	244.60M	198.40M	293.80M	167.90M	184.70M
Operating Cash Flow	409.60M	409.60M	350.10M	439.90M	286.80M	265.80M
Investing Cash Flow	-330.90M	-327.70M	-226.80M	-267.00M	-405.90M	-120.50M
Financing Cash Flow	-120.00M	-120.00M	-3.10M	-121.20M	77.40M	-379.90M

ALS Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 22.01
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:ALQ, the sentiment is Positive. The current price of 22.01 is above the 20-day moving average (MA) of 21.45, above the 50-day MA of 21.15, and above the 200-day MA of 17.92, indicating a bullish trend. The MACD of 0.06 indicates Negative momentum. The RSI at 60.36 is Neutral, neither overbought nor oversold. The STOCH value of 71.35 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:ALQ.

ALS Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
VNT	73 Outperform	AU$4.73B	19.05	42.87%	3.74%	1.48%	25.46%
ALQ	66 Neutral	$11.10B	41.37	18.38%	1.76%	18.18%	4272.22%
MND	65 Neutral	€2.26B	26.81	17.57%	2.65%	7.20%	32.60%
DOW	64 Neutral	€5.09B	37.49	6.66%	3.21%	-4.53%	97.67%
Sector *	63 Neutral	$10.79B	15.43	7.44%	2.01%	2.89%	-14.66%
NWH	63 Neutral	€2.17B	77.89	4.71%	3.11%	12.18%	-73.81%
MGH	56 Neutral	AU$1.66B	21.91	9.26%	1.59%	15.14%	-7.23%

ALS Corporate Events

ALS Limited Issues Unquoted Equity Securities for Employee Incentive

ALS Limited has announced the issuance of unquoted equity securities, specifically performance rights and service rights, as part of an employee incentive scheme. This move reflects ALS Limited’s ongoing commitment to employee engagement and retention, potentially enhancing its operational efficiency and market competitiveness.

The most recent analyst rating on (AU:ALQ) stock is a Buy with a A$24.60 price target. To see the full list of analyst forecasts on ALS stock, see the AU:ALQ Stock Forecast page.

ALS Limited Announces Issuance of Unquoted Equity Securities

ALS Limited has announced the issuance and conversion of unquoted equity securities, specifically ordinary fully paid shares, totaling 552,093 shares. This move reflects the company’s ongoing efforts to manage its capital structure and may impact its market positioning by potentially increasing liquidity and shareholder value.

The most recent analyst rating on (AU:ALQ) stock is a Buy with a A$24.60 price target. To see the full list of analyst forecasts on ALS stock, see the AU:ALQ Stock Forecast page.

ALS Limited Appoints New Director Christina Boyce

ALS Limited has announced the appointment of Christina Boyce as a new director, effective from September 1, 2025. This appointment is part of the company’s ongoing efforts to strengthen its leadership team, although the notice indicates that she currently holds no relevant interests in the company’s securities, suggesting a focus on governance and strategic oversight rather than financial influence.

The most recent analyst rating on (AU:ALQ) stock is a Hold with a A$19.00 price target. To see the full list of analyst forecasts on ALS stock, see the AU:ALQ Stock Forecast page.

ALS Limited Announces Director’s Share Acquisition

ALS Limited has announced a change in the director’s interest notice, specifically regarding Siddhartha Kadia. The change involves an acquisition of 4,910 ordinary shares by the Kadia/Perekh Family Trust, increasing their total holdings to 14,290 shares. This transaction, valued at USD 59,236.61, was conducted through an on-market trade.

The most recent analyst rating on (AU:ALQ) stock is a Hold with a A$19.00 price target. To see the full list of analyst forecasts on ALS stock, see the AU:ALQ Stock Forecast page.

ALS Limited Announces Director’s Share Acquisition

ALS Limited has announced a change in the director’s interest, with Nigel Garrard acquiring 1,328 ordinary shares through an on-market trade, valued at $24,966.40. This change reflects a minor adjustment in the director’s shareholding, potentially indicating confidence in the company’s future prospects, which could have implications for shareholder perception and market confidence.

The most recent analyst rating on (AU:ALQ) stock is a Hold with a A$19.00 price target. To see the full list of analyst forecasts on ALS stock, see the AU:ALQ Stock Forecast page.

ALS Limited Director Acquires Significant Shareholding

ALS Limited has announced a change in the director’s interest, specifically concerning Erica Mann, who has acquired 5,930 ordinary shares valued at $108,044.60 through an on-market trade. This acquisition marks a significant personal investment by the director, potentially indicating confidence in the company’s future performance and aligning her interests with those of the shareholders.

The most recent analyst rating on (AU:ALQ) stock is a Buy with a A$16.25 price target. To see the full list of analyst forecasts on ALS stock, see the AU:ALQ Stock Forecast page.

ALS Limited Hosts 2025 Investor Days, Emphasizing Future Lab Innovations

ALS Limited is hosting its 2025 Investor Days event, where management will present a series of live and online presentations. This event underscores ALS’s commitment to innovation and its strategic focus on advancing towards the ‘lab of the future,’ potentially impacting its operational efficiency and industry positioning.

The most recent analyst rating on (AU:ALQ) stock is a Buy with a A$14.20 price target. To see the full list of analyst forecasts on ALS stock, see the AU:ALQ Stock Forecast page.

ALS Limited Announces Results of 2025 Annual General Meeting

ALS Limited held its 2025 Annual General Meeting where all resolutions, including the election and re-election of directors and the renewal of proportional takeover approval provisions, were carried. The outcomes of the meeting reflect strong shareholder support, indicating confidence in the company’s strategic direction and leadership.

The most recent analyst rating on (AU:ALQ) stock is a Buy with a A$16.15 price target. To see the full list of analyst forecasts on ALS stock, see the AU:ALQ Stock Forecast page.

ALS Limited Announces Resignation of Non-Executive Director

ALS Limited announced the resignation of Tonianne Dwyer as a Non-Executive Director, effective after the Annual General Meeting on July 30, 2025. Ms. Dwyer, who has been on the Board since 2016, has been acknowledged for her valuable contributions and governance expertise. Her departure may impact the company’s board dynamics and governance structure.

The most recent analyst rating on (AU:ALQ) stock is a Buy with a A$16.15 price target. To see the full list of analyst forecasts on ALS stock, see the AU:ALQ Stock Forecast page.

ALS Limited’s Strategic Advancements and FY25 Performance

ALS Limited’s FY25 performance was marked by resilience despite geopolitical uncertainties and market volatility. The company has strengthened its leadership team and is focusing on innovation, agility, and growth. ALS has introduced a value creation framework targeting organic revenue growth and improved margins, supported by digital transformation and sustainability initiatives. The company completed an equity raising to fund the development of hub facilities, enhancing its testing services with automation and AI, positioning ALS as a leader in next-generation analytical testing.

The most recent analyst rating on (AU:ALQ) stock is a Buy with a A$16.15 price target. To see the full list of analyst forecasts on ALS stock, see the AU:ALQ Stock Forecast page.

ALS Limited Reports Strong FY25 Performance and Strategic Investments

In the 2025 financial year, ALS Limited achieved a 16% revenue growth to $3 billion, despite macroeconomic challenges, and maintained a strong operating margin of 19.1%. The company declared a final dividend of 19.7%, supported by a disciplined capital management strategy that included a $350 million equity raise to fund laboratory upgrades and future acquisitions. These investments aim to enhance capacity, efficiency, and market share, while maintaining flexibility and reducing environmental risks. ALS’s strategic focus on organic and inorganic growth positions it to benefit from industry trends and deliver sustainable, above-market growth.

The most recent analyst rating on (AU:ALQ) stock is a Buy with a A$16.15 price target. To see the full list of analyst forecasts on ALS stock, see the AU:ALQ Stock Forecast page.